Several studies have shown that a hypertensive response to exercise (HRE) predicts the future development of essential hypertension, 1,2 coronary disease, 3 left ventricular (LV) mass, 4 cardiovascular events 5, 6 and mortality, 7 independent of resting blood pressure (BP) in apparently healthy, nonhypertensive (office BP <140/90 mm Hg) individuals. The physiological reason for the additional prognostic value of exercise BP, beyond that of resting measures, remains unresolved. However, a limitation of previous investigations [1] [2] [3] [5] [6] [7] is that office BP readings have been solely relied upon to determine BP status. This methodology fails to identify the presence of masked hypertension (office BP that is normal/nonhypertensive but hypertensive ambulatory BP); a condition that is associated with increased LV mass 8,9 and cardiovascular mortality 10 irrespective of office BP.
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Several studies have shown that a hypertensive response to exercise (HRE) predicts the future development of essential hypertension, 1,2 coronary disease, 3 left ventricular (LV) mass, 4 cardiovascular events 5, 6 and mortality, 7 independent of resting blood pressure (BP) in apparently healthy, nonhypertensive (office BP <140/90 mm Hg) individuals. The physiological reason for the additional prognostic value of exercise BP, beyond that of resting measures, remains unresolved. However, a limitation of previous investigations [1] [2] [3] [5] [6] [7] is that office BP readings have been solely relied upon to determine BP status. This methodology fails to identify the presence of masked hypertension (office BP that is normal/nonhypertensive but hypertensive ambulatory BP); a condition that is associated with increased LV mass 8, 9 and cardiovascular mortality 10 irrespective of office BP.
Presently, hypertension management guidelines make no specific recommendations for patients presenting with masked hypertension, and little (or no) consideration is given to the BP response to exercise. 11, 12 The first aim of this study was to determine the prevalence of masked hypertension in otherwise healthy, nonhypertensive (by office BP) patients with an HRE. We hypothesized that there would be a high prevalence of masked hypertension in this patient population. Second, considering that hypertension-related end organ damage is more closely associated with ambulatory BP rather than office BP, 13 we also hypothesized that patients with masked hypertension would have increased LV mass compared to patients without masked hypertension.
Finally, scant data is available on the determinants of an HRE. It is expected that a noncompliant aorta would not be able to accept the increased stroke volume associated with Background a hypertensive response to exercise (HRE; defined as normal clinic blood pressure (BP) and exercise systolic BP (sBP) ≥210 mm Hg in men or ≥190 mm Hg in women, or diastolic BP (DBP) ≥105 mm Hg) independently predicts mortality. the mechanisms remain unclear but may be related to masked hypertension. this study aimed to assess the prevalence of masked hypertension and its association with cardiovascular risk factors, including left ventricular (LV) mass, in patients with a HRE.
methodS
Comprehensive clinical and echocardiographic evaluation (including central BP, aortic pulse wave velocity by tonometry) and 24-h ambulatory BP monitoring (aBPM) were performed in 72 untreated patients with HRE (aged 54 ± 9 years; 60% male; free from coronary artery disease confirmed by exercise stress echocardiography). Masked hypertension was defined according to guidelines as daytime aBPM ≥135/85 mm Hg and clinic BP <140/90 mm Hg.
reSultS
Masked hypertension was present in 42 patients (58%). these patients had higher LV mass index (41.5 ± 8.7g/m 2.7 vs. 35.9±8.5g/m 2.7 ; P = 0.01), LV relative wall thickness (RWt; 0.42 ± 0.09 vs. 0.37 ± 0.06; P = 0.004) and exercise sBP (222 ± 17 mm Hg vs. 212±14 mm Hg; P = 0.01), but no significant difference in aortic pulse wave velocity or central pulse pressure (P > 0.05 for both). the strongest independent determinant of LV mass index was the presence of masked hypertension (unstandardized β = 5.6; P = 0.007), which was also independently related to LV RWt (unstandardized β = 0.04; P = 0.03).
original contributions
Exercise BP and masked hypertension exercise without an exaggerated increase in BP. Accordingly, this study also aimed to determine the aortic stiffness (pulse wave velocity), as well as the estimated central hemodynamics (pulse pressure and augmentation index) in patients presenting with an HRE. We hypothesized that aortic pulse wave velocity would significantly correlate with exercise BP.
methodS
Subjects. One hundred and one consecutive patients were identified and recruited using exercise stress testing records from both tertiary hospital and community-based clinics. Only healthy participants free from factors which may affect the exercise BP response were studied. Inclusion criteria included an exercise stress echocardiogram that was negative for ischemia, office BP <140/90 mm Hg (on two separate clinic visits) and an HRE (defined as brachial systolic BP (SBP) ≥210 mm Hg (men) or ≥190 mm Hg (women) or diastolic BP (DBP) ≥105 mm Hg in either men or women). 1, 14, 15 Patients were excluded if they had previously been diagnosed with hypertension or were currently taking antihypertensive medication. Further exclusionary criteria included a clinical history of cardiovascular or renal disease assessed by medical records and/or self report. Twenty patients with resting BP ≥140/90 mm Hg and nine patients with type 2 diabetes were excluded from analysis (final study n = 72). The Princess Alexandra Hospital Research Ethics Committee approved all procedures and subjects gave written informed consent.
Study protocol. Subjects were studied in a quiet temperaturecontrolled hospital room (23 ± 2 °C). All subjects underwent resting echocardiography in addition to assessment of arterial stiffness, brachial and central BP. Subjects then underwent maximal treadmill exercise stress echocardiography (Bruce protocol) with expired gas analysis (V29C Sensormedics, Yorba Linda, CA) for determination of maximal cardiorespiratory capacity (VO 2 max). Exercise BP was recorded at each stage, and in the last minute of the stress test. Each subject was then fitted with an ambulatory BP monitor (ABPM; TM-2430; A&D Medical, Thebarton, Australia) 16 which was programmed to record BP every 30 min during the day (6:00 am to 10:00 pm) and every 60 min overnight (10:00 pm to 6:00 am). The average ABPM taken over each time period (i.e., day, night, 24 h) was used for analysis and there was no trimming of outlying BP values unless physiologically implausible (e.g., if DBP equaled SBP). 17 On a second visit (within 7 days), a fasted blood sample was obtained for standard biochemical analysis.
Echocardiography. All patients underwent comprehensive twodimensional transthoracic echocardiography with a 2.5-MHz phased array probe using commercially available equipment (Vivid 7; GE Medical Systems, Milwaukee, WI). LV mass was calculated from end-diastolic M-mode or 2D-guided anatomic M-mode measurements of the ventricular septum, LV internal diameter and posterior wall thickness, according to the method of Devereux, 18 and indexed to height 2.7 (g/m 2.7 ; left ventricular mass index (LVMI)). 19 Measurement of LV end-diastolic volume, LV end-systolic volume and ejection fraction was obtained from the apical four and two-chamber views using the Simpson's biplane method, in accordance with the American Society of Echocardiography guidelines. 20 Relative wall thickness (RWT) was calculated as the ratio of 2 × posterior wall thickness to LV diameter and normal RWT was defined as ≤0.42 according to Lang et al. 20 Sex-specific LV hypertrophy was defined as LVMI >48 g/m 2.7 for men and >44 g/m 2.7 for women. Normal LV geometry was defined as normal RWT and normal LVMI (≤48 g/m 2.7 for men and ≤44 g/m 2.7 for women); concentric remodeling was increased RWT (>0.42) and normal LVMI; concentric hypertrophy was increased RWT and increased LVMI, whereas eccentric hypertrophy was normal RWT and increased LVMI. 20 Stroke volume was defined as the difference between LV end-diastolic and end-systolic volumes. Left atrial area was measured from the apical four-chamber view in ventricular end-systole. Doppler interrogation of the mitral inflow was used to measure the early diastolic deceleration time, with pulsed wave Doppler of the septal mitral annulus used to measure the peak systolic tissue velocity (Sm) and the early diastolic tissue velocity (Em). Color-coded tissue Doppler images were used to extract strain and strain rate curves with peak systolic longitudinal strain and peak systolic longitudinal strain rate measured offline by a single observer (Echopac; GE VingMed, Horten, Norway) and reported as the average of six basal segments. 21 Cardiac output was calculated as stroke volume × heart rate. Peripheral vascular resistance was calculated by mean arterial pressure (mm Hg)/cardiac output (cm 3 min −1 ) × 1,000 expressed as peripheral resistance units.
Arterial stiffness. Aortic pulse wave velocity was recorded as a measure of regional stiffness by electrocardiogram-gated sequential applanation tonometry (SphygmoCor 7.01; AtCor Medical, Sydney, Australia) as previously described. 22 Using the same device, central augmentation index (AIx; a measure of systemic arterial stiffness) was recorded by hand held radial applanation tonometry as we have described before. 15 AIx values corrected to a heart rate of 75 bpm were also calculated with the SphygmoCor software.
Brachial and central BP. Brachial SBP and DBP were recorded as the average of two readings using mercury sphygmomanometry as recommended. 23 Masked hypertension was defined by seated office BP <140/90 mm Hg and daytime ABPM ≥135/85 mm Hg. 24 The absence of masked hypertension was defined as seated office BP <140/90 mm Hg and ABPM BP <135/85 mm Hg. Resting seated central BP was estimated by hand held radial tonometry (SphygmoCor version 7.01; AtCor Medical) using a validated transfer function. 25 Correct cuff sizes were used for all BP monitoring.
Statistics. Data are presented as mean ± s.d. and were analyzed using SPSS software (version 14; SPSS Inc., Chicago, IL) with significance considered at P < 0.05. Between-group comparisons of continuous variables were assessed by independent t-tests or analysis of covariance where stated. The relation original contributions Exercise BP and masked hypertension between categorical variables was determined by the χ 2 test for independence with Yates Correction for Continuity. Pearson r correlations were used to assess relationships between continuous variables, whereas Spearman correlations were used to compare categorical variables with continuous variables. Multiple regression was performed by the backward stepwise method. Variables that were significantly correlated (P < 0.05), or those expected (e.g., age, sex) to be related with the dependent variable of interest were included in the multiple regression models. Models were checked to ensure there was no multicollinearity (cut points were a tolerance <0.10 or a variance inflation factor >10).
reSultS
The study population were aged 54 ± 9 years, with body mass index 28.6 ± 3.9 kg/m 2 , and comprised 43 (60%) males. Only three participants were current smokers. Forty two subjects (58%) had masked hypertension, with the remainder having normal 24-h ABPM. Baseline characteristics and hemodynamics of these subject groups are presented in Table 1 . Subjects with masked hypertension had significantly higher LVMI, LV RWT, LV early mitral inflow deceleration time and brachial SBP. Aortic pulse wave velocity, AIx, and central pulse pressure were not significantly different between groups when assessed by t-test or after correction for age, mean arterial pressure and sex (P > 0.28 for all). All ABPM variables, as well as maximal exercise brachial BP (SBP, 222 ± 17 mm Hg vs. 212 ± 14; P = 0.01 and DBP 96 ± 12 mm Hg vs. 90 ± 10 mm Hg; P = 0.02), were significantly elevated in the group with masked hypertension (Figure 1) . Exercise DBP was raised beyond the cut point of 105 mm Hg in 18 participants (12 males) and this was accompanied by exaggerated SBP in all but one male participant who had an isolated exaggerated DBP response to exercise (205/110 mm Hg).
correlates of exercise BP
Peak exercise SBP was significantly correlated with male gender (r = 0.56; P < 0.001), masked hypertension (r = 0.30; P = 0.01), 24-h ABPM SBP (r = 0.36; P = 0.002), daytime ABPM SBP (r = 0.33; P = 0.005), resting brachial SBP (r = 0.51; P < 0.001), central SBP (r = 0.33; P = 0.005), aortic pulse wave velocity (r = 0.25; P = 0.04) and augmentation index (r = −0.29; P = 0.01), but not central pulse pressure (r = 0.16; P = 0.18). These variables (excepting central pulse pressure due to nonsignificance and central SBP due to collinearity with brachial SBP) were entered into a multiple regression model and the results are presented in Table 2 . Due to collinearity between daytime ABPM SBP and 24-h ABPM SBP (r = 0.97; P < 0.001), these variables were included separately. Neither variable was independently correlated with peak exercise SBP, and the model adjusted R 2 and P values were unchanged with inclusion of either variable. The only independent correlates of peak exercise SBP were sex (higher in men) and office brachial SBP. According to the model, a 1 mm Hg increase in resting brachial SBP equated to a 0.66 mm Hg increase in peak exercise brachial SBP.
correlates of lv mass
Multiple regression models for predictors of LVMI and LV RWT were constructed, with the following variables entered as Tables 3 and 4 . Aortic pulse wave velocity was not related to LVMI (r = −0.13; P = 0.13) or LV RWT (r = 0.20; P = 0.10) on univariate analysis and did not change the multiple regression models. Inclusion of daytime ABPM SBP instead of 24-h ABPM SBP did not change the adjusted R 2 or P values in either models for predictors of LVMI or LV RWT.
diScuSSion
The principal novel finding of this study was a high prevalence (58%) of masked hypertension in apparently healthy patients presenting with normal office BP but high BP during a clinically indicated exercise stress test. We also Numerous small scale [26] [27] [28] and larger studies 1,2 consistently show that exaggerated BP during or after exercise predicts the future development of essential hypertension in people with normal BP. Since these studies used office BP rather than ABPM to define normotension, it is possible that a high proportion of the HRE patients already had hypertension at baseline, which was masked and only became apparent after several years of follow-up. Masked hypertension is prevalent in hypertension outpatient clinics (14.5%). 8 However, the prevalence of masked hypertension in HRE patients from this current study was fourfold this value highlighting the importance of an exercise stress test as a screening tool for masked hypertension. We, 15 and others 4, 14 have observed an independent association between exercise BP and LV mass. However, ABPM was not undertaken in any of these former studies, and the role of masked hypertension on cardiac structure was, therefore, undetermined. Raised LV mass in untreated patients with masked hypertension has previously been reported 8, 9 and is a likely contributor to the additional risk in this population for cardiovascular events and all-cause mortality. 10, 29 Our findings provide the first preliminary evidence as to why an exaggerated exercise BP may foreshadow incident hypertension, 1,2 myocardial infarction, 6 stroke, 5 and cardiovascular death. 7 The mechanisms underlying the association with poor outcomes cannot be derived from this current study and more studies are needed to determine this. Although aortic stiffness and augmentation index correlated with exercise SBP, the associations were only weak and there were no significant differences between groups for these variables. It may be that the drivers of abnormal exercise BP may be most apparent during exercise itself (e.g., exercise aortic stiffness), given this is a modality that "unmasks" the BP abnormality.
limitations
The main limitation of this study was the lack of a reference control group of participants without HRE, and this should be considered in future studies. Furthermore, a bout of intense aerobic exercise can lower BP for up to 24 h after ceasing exercise. Since we measured 24-h ABPM in the period after the maximal exercise stress test, the true prevalence of masked hypertension may have been underestimated. In addition, there appeared to be a trend toward higher prevalence of adverse LV concentric and eccentric geometry between patients with and without masked hypertension ( Table 1) . None of these comparisons reached statistical significance, but this may have been because the study was underpowered to assess this appropriately.
Summary and significance
The most important clinical result of this study was the common presence of masked hypertension in patients with normal clinic BP (<140/90 mm Hg) but exercise BP ≥210/105 mm Hg for men, or ≥190/105 mm Hg for women. Despite the presence of masked hypertension carrying significantly increased risk for both cardiovascular and all-cause mortality, 10 current guidelines for the evaluation and treatment of high BP do not consider either masked hypertension or exaggerated exercise BP as clinical situations in which the use of 24-ABPM may be helpful. 11, 12 This study may shed light on the disproportionate cardiovascular risk associated with exaggerated exercise BP, and implies that clinicians should consider measuring ABPM or home BP in these patients. 
